Company registration number 00964829 (England and Wales)
HAMMOND CHEMICALS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
HAMMOND CHEMICALS LIMITED
COMPANY INFORMATION
DIRECTORS
Mr M J Dominik
Mr T R E Normanton
Mr M G Silver
Mr J E Ward
COMPANY NUMBER
00964829
REGISTERED OFFICE
Canal Street
Brierley Hill
West Midlands
DY5 1JR
AUDITOR
JW Hinks LLP
Chartered Accountants
19 Highfield Road
Edgbaston
Birmingham
B15 3BH
HAMMOND CHEMICALS LIMITED
CONTENTS
PAGE
Strategic report
1
Directors' report
3
Directors' responsibilities statement
2
Independent auditor's report
4 - 6
Profit and loss account
7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 27
HAMMOND CHEMICALS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -
The directors present the strategic report for the year ended 31 December 2024.
PRINCIPAL ACTIVITIES
The principal activities of the company continued to be that of blending, packing and distribution of industrial solvents to a wide variety of industrial and commercial sectors predominantly within the UK.
REVIEW OF THE BUSINESS
The results for the year are set out in the following pages.
PRINCIPAL RISKS AND UNCERTAINTIES
The principal risks to the business are a general economic downturn and supply chain shortages. These can cause imbalances in supply, demand and value.
While the business is broad based, a multi-sector downturn could impact our end customers' business and hence lower demand or increase credit issues.
Supply chain issues can extend beyond just the main purchase of solvents. The company needs equipment, parts and other materials to continue operations. As such, the broad supply chain shortages for items like lorries could be a risk to the company.
DEVELOPMENT AND PERFORMANCE
We continue to invest in the business to add capacity, meet regulatory requirements and exploit commercial opportunities.
For the reasons stated above, we expect the business environment to remain challenging but we continue to actively manage the situation.
KEY PERFORMANCE INDICATORS
Sales revenue decreased during the year for reasons stated above by 9.2%. Gross profit increased by 15.8% and operating profit decreased by 27.6%.
Mr J E Ward
DIRECTOR
14 August 2025
HAMMOND CHEMICALS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
HAMMOND CHEMICALS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
The directors present their annual report and financial statements for the year ended 31 December 2024.
RESULTS AND DIVIDENDS
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £3,645,000. The directors do not recommend payment of a further dividend.
DIRECTORS
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr M J Dominik
Mr T R E Normanton
Mr M G Silver
Mr J E Ward
STATEMENT OF DISCLOSURE TO AUDITOR
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
Mr J E Ward
DIRECTOR
14 August 2025
HAMMOND CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HAMMOND CHEMICALS LIMITED
- 4 -
OPINION
We have audited the financial statements of Hammond Chemicals Limited (the 'company') for the year ended 31 December 2024 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
BASIS FOR OPINION
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
CONCLUSIONS RELATING TO GOING CONCERN
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
OTHER INFORMATION
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
OPINIONS ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
HAMMOND CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HAMMOND CHEMICALS LIMITED (CONTINUED)
- 5 -
MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
RESPONSIBILITIES OF DIRECTORS
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
AUDITOR'S RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Extent to which the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.
We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.
In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:
Enquiry of management and those charged with governance around actual and potential litigation and claims as well as actual, suspected and alleged fraud;
Assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the entity through enquiry and inspection;
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of potential bias.
HAMMOND CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF HAMMOND CHEMICALS LIMITED (CONTINUED)
- 6 -
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
USE OF OUR REPORT
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
MARCUS ROSE FCA CTA (SENIOR STATUTORY AUDITOR)
CHARTERED ACCOUNTANTS
STATUTORY AUDITOR
19 HIGHFIELD ROAD
EDGBASTON
BIRMINGHAM
B15 3BH
14 AUGUST 2025
14 August 2025
HAMMOND CHEMICALS LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
2024
2023
Notes
£
£
TURNOVER
6
17,845,677
19,660,040
Cost of sales
(12,909,460)
(13,785,450)
GROSS PROFIT
4,936,217
5,874,590
Distribution costs
(864,520)
(744,773)
Administrative expenses
(1,232,576)
(1,205,694)
OPERATING PROFIT
3
2,839,121
3,924,123
Interest receivable and similar income
8
110,970
118,145
Interest payable and similar expenses
9
(20,567)
(6,971)
PROFIT BEFORE TAXATION
2,929,524
4,035,297
Tax on profit
10
(456,891)
(663,363)
PROFIT FOR THE FINANCIAL YEAR
2,472,633
3,371,934
The profit and loss account has been prepared on the basis that all operations are continuing operations.
HAMMOND CHEMICALS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
2024
2023
£
£
PROFIT FOR THE YEAR
2,472,633
3,371,934
OTHER COMPREHENSIVE INCOME
-
-
TOTAL COMPREHENSIVE INCOME FOR THE YEAR
2,472,633
3,371,934
HAMMOND CHEMICALS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
Notes
£
£
£
£
FIXED ASSETS
Intangible assets
12
60,336
79,862
Tangible assets
13
905,558
831,137
Investments
14
1,159,824
1,718,347
2,125,718
2,629,346
CURRENT ASSETS
Stocks
16
535,071
649,712
Debtors
17
13,218,954
13,645,452
Cash at bank and in hand
802,247
1,234,076
14,556,272
15,529,240
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
18
(1,559,438)
(1,935,836)
NET CURRENT ASSETS
12,996,834
13,593,404
TOTAL ASSETS LESS CURRENT LIABILITIES
15,122,552
16,222,750
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
19
(229,558)
(191,289)
PROVISIONS FOR LIABILITIES
Deferred tax liability
22
213,332
179,432
(213,332)
(179,432)
NET ASSETS
14,679,662
15,852,029
CAPITAL AND RESERVES
Called up share capital
24
10,000
10,000
Profit and loss reserves
14,669,662
15,842,029
TOTAL EQUITY
14,679,662
15,852,029
The financial statements were approved by the board of directors and authorised for issue on 14 August 2025 and are signed on its behalf by:
Mr J E Ward
DIRECTOR
Company registration number 00964829 (England and Wales)
HAMMOND CHEMICALS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
BALANCE AT 1 JANUARY 2023
10,000
13,280,095
13,290,095
YEAR ENDED 31 DECEMBER 2023:
Profit and total comprehensive income
-
3,371,934
3,371,934
Dividends
11
-
(810,000)
(810,000)
BALANCE AT 31 DECEMBER 2023
10,000
15,842,029
15,852,029
YEAR ENDED 31 DECEMBER 2024:
Profit and total comprehensive income
-
2,472,633
2,472,633
Dividends
11
-
(3,645,000)
(3,645,000)
BALANCE AT 31 DECEMBER 2024
10,000
14,669,662
14,679,662
HAMMOND CHEMICALS LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
2024
2023
Notes
£
£
£
£
CASH FLOWS FROM OPERATING ACTIVITIES
Cash generated from/(absorbed by) operations
28
3,231,365
(6,672,844)
Interest paid
(20,567)
(6,971)
Income taxes paid
(469,062)
(1,019,240)
NET CASH INFLOW/(OUTFLOW) FROM OPERATING ACTIVITIES
2,741,736
(7,699,055)
INVESTING ACTIVITIES
Purchase of intangible assets
(9,419)
(79,862)
Purchase of tangible fixed assets
(155,478)
(81,940)
Proceeds from disposal of tangible fixed assets
10,250
5,000
Net proceeds from disposal of investments
558,523
(1,717,847)
Interest received
110,970
118,145
NET CASH GENERATED FROM/(USED IN) INVESTING ACTIVITIES
514,846
(1,756,504)
FINANCING ACTIVITIES
Payment of finance leases obligations
(43,411)
Dividends paid
(3,645,000)
(810,000)
NET CASH USED IN FINANCING ACTIVITIES
(3,688,411)
(810,000)
NET DECREASE IN CASH AND CASH EQUIVALENTS
(431,829)
(10,265,559)
Cash and cash equivalents at beginning of year
1,234,076
11,499,635
CASH AND CASH EQUIVALENTS AT END OF YEAR
802,247
1,234,076
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
1
ACCOUNTING POLICIES
COMPANY INFORMATION
Hammond Chemicals Limited is a private company limited by shares incorporated in England and Wales. The registered office is Canal Street, Brierley Hill DY5 1JR.
The group consists of Hammond Chemicals Limited and all of its subsidiaries.
1.1
BASIS OF PREPARATION
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.
Hammond Chemicals Limited is a wholly owned subsidiary of Dudley Industrial Holdings Limited and the results of Hammond Chemicals Limited are included in the consolidated financial statements of Dudley Industrial Holdings Limited which are available from 73 Cornhill, London. EC3V 3QQ.
1.2
GOING CONCERN
At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true
After reviewing the group’s forecast and making enquiries, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future and meets its liabilities as they fall due for at last 12 months from the date of approval of these financial statements. Therefore, they continue to adopt the going concern basis in preparing the annual report and financial statements.
1.3
TURNOVER
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.
The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 13 -
1.4
INTANGIBLE FIXED ASSETS OTHER THAN GOODWILL
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software
33% straight line
1.5
TANGIBLE FIXED ASSETS
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
4% straight line
Plant and equipment
15% reducing balance
Computers
33% straight line
Motor vehicles
25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
FIXED ASSET INVESTMENTS
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.7
IMPAIRMENT OF FIXED ASSETS
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 14 -
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.8
STOCKS
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.9
CASH AND CASH EQUIVALENTS
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.10
FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 15 -
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 16 -
1.11
EQUITY INSTRUMENTS
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.12
TAXATION
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.13
EMPLOYEE BENEFITS
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.14
RETIREMENT BENEFITS
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.15
LEASES
As lessee
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 17 -
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
2
JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
OPERATING PROFIT
2024
2023
Operating profit for the year is stated after charging/(crediting):
£
£
Depreciation of tangible fixed assets
115,989
129,485
Depreciation on assets held under Hire Purchase
60,489
Profit on disposal of tangible fixed assets
(3,571)
(4,349)
Amortisation of intangible assets
28,945
-
Operating lease charges
50,000
43,750
4
AUDITOR'S REMUNERATION
2024
2023
Fees payable to the company's auditor and associates:
£
£
FOR AUDIT SERVICES
Audit of the financial statements of the company
9,250
9,250
FOR OTHER SERVICES
All other non-audit services
3,200
8,200
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 18 -
5
EMPLOYEES
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Management
4
3
Adminisration
4
4
Production
10
9
Selling & Delivery
7
7
Total
25
23
Their aggregate remuneration comprised:
2024
2023
£
£
Wages and salaries
1,105,879
852,429
Social security costs
88,098
71,397
Pension costs
15,063
12,056
1,209,040
935,882
6
TURNOVER AND OTHER REVENUE
2024
2023
£
£
TURNOVER ANALYSED BY CLASS OF BUSINESS
Sales of Goods
17,845,677
19,660,040
2024
2023
£
£
TURNOVER ANALYSED BY GEOGRAPHICAL MARKET
United Kingdom
17,750,892
19,591,125
Ireland
94,785
68,915
17,845,677
19,660,040
2024
2023
£
£
OTHER REVENUE
Interest income
110,970
118,145
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 19 -
7
DIRECTORS' REMUNERATION
2024
2023
£
£
Remuneration for qualifying services
165,000
132,834
Company pension contributions to defined contribution schemes
1,321
770
166,321
133,604
8
INTEREST RECEIVABLE AND SIMILAR INCOME
2024
2023
£
£
INTEREST INCOME
Interest on bank deposits
109,697
117,455
Other interest income
1,273
690
Total income
110,970
118,145
2024
2023
Investment income includes the following:
£
£
Interest on financial assets not measured at fair value through profit or loss
109,697
117,455
9
INTEREST PAYABLE AND SIMILAR EXPENSES
2024
2023
£
£
OTHER FINANCE COSTS:
Interest on finance leases and hire purchase contracts
19,423
522
Other interest
1,144
6,449
20,567
6,971
10
TAXATION
2024
2023
£
£
CURRENT TAX
UK corporation tax on profits for the current period
422,991
601,400
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
10
TAXATION
2024
2023
£
£
(Continued)
- 20 -
DEFERRED TAX
Origination and reversal of timing differences
33,900
61,963
Total tax charge
456,891
663,363
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Profit before taxation
2,929,524
4,035,297
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
732,381
949,102
Tax effect of expenses that are not deductible in determining taxable profit
130
122
Group relief
(292,976)
(300,925)
Permanent capital allowances in excess of depreciation
(16,544)
(46,899)
Deferred tax movement
33,900
61,963
Taxation charge for the year
456,891
663,363
11
DIVIDENDS
2024
2023
£
£
Interim paid
3,645,000
810,000
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 21 -
12
INTANGIBLE FIXED ASSETS
Software
£
COST
At 1 January 2024
79,862
Additions
9,419
At 31 December 2024
89,281
AMORTISATION AND IMPAIRMENT
At 1 January 2024
Amortisation charged for the year
28,945
At 31 December 2024
28,945
CARRYING AMOUNT
At 31 December 2024
60,336
At 31 December 2023
79,862
13
TANGIBLE FIXED ASSETS
Freehold land and buildings
Plant and equipment
Computers
Motor vehicles
Total
£
£
£
£
£
COST
At 1 January 2024
391,975
1,492,812
137,436
902,436
2,924,659
Additions
91,198
1,160
165,220
257,578
Disposals
(129,252)
(129,252)
At 31 December 2024
391,975
1,584,010
138,596
938,404
3,052,985
DEPRECIATION AND IMPAIRMENT
At 1 January 2024
373,040
971,956
124,767
623,759
2,093,522
Depreciation charged in the year
15,679
81,798
4,423
74,578
176,478
Eliminated in respect of disposals
(122,573)
(122,573)
At 31 December 2024
388,719
1,053,754
129,190
575,764
2,147,427
CARRYING AMOUNT
At 31 December 2024
3,256
530,256
9,406
362,640
905,558
At 31 December 2023
18,935
520,856
12,669
278,677
831,137
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
13
TANGIBLE FIXED ASSETS
(Continued)
- 22 -
Tangible fixed assets includes assets held under finance leases or hire purchase contracts, as follows:
2024
2023
£
£
Plant and equipment
87,950
103,471
Motor vehicles
274,172
149,921
362,122
253,392
Assets held under finance leases are secured against the assets purchased.
14
FIXED ASSET INVESTMENTS
2024
2023
Notes
£
£
Investments in subsidiaries
15
500
500
Listed investments
1,159,324
1,717,847
1,159,824
1,718,347
MOVEMENTS IN FIXED ASSET INVESTMENTS
Shares in subsidiaries
Other investments
Total
£
£
£
COST OR VALUATION
At 1 January 2024
500
1,717,847
1,718,347
Additions
-
350,000
350,000
Interest Recieved
-
91,477
91,477
Withdrawls
-
(1,000,000)
(1,000,000)
At 31 December 2024
500
1,159,324
1,159,824
CARRYING AMOUNT
At 31 December 2024
500
1,159,324
1,159,824
At 31 December 2023
500
1,717,847
1,718,347
15
SUBSIDIARIES
Details of the company's subsidiaries at 31 December 2024 are as follows:
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
15
SUBSIDIARIES
(Continued)
- 23 -
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
N. and S. Hammond Limited
Canal Street, Brierley Hill, Staffs, DY5 1JR
Ordinary
100.00
N. & S. Chemicals Limited
Canal Street, Brierley Hill, Staffs, DY5 1JR
Ordinary
100.00
Hamsol Limited
Canal Street, Brierley Hill, Staffs, DY5 1JR
Ordinary
100.00
Hammond Solvents Limited
Canal Street, Brierley Hill, Staffs, DY5 1JR
Ordinary
100.00
Hammond Organic Products Limited
Canal Street, Brierley Hill, Staffs, DY5 1JR
Ordinary
100.00
16
STOCKS
2024
2023
£
£
Finished goods and goods for resale
535,071
649,712
17
DEBTORS
2024
2023
AMOUNTS FALLING DUE WITHIN ONE YEAR:
£
£
Trade debtors
2,499,114
2,841,087
Amounts owed by group undertakings
10,669,335
10,669,335
Other debtors
2,380
Prepayments and accrued income
50,505
132,650
13,218,954
13,645,452
During the year ended 31st December 2023, the company entered into a loan agreement with Dudley Industrial Holdings Limited for the amount of £10,669,335.
The loan is unsecured and carries no rate of interest. The loan is repayable on demand by Hammond Chemicals.
The balance of the loan represents the entire amount owed by group undertakings at the balance sheet date. There has been no movement in the loan balance during the year ended 31st December 2024.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 24 -
18
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
Notes
£
£
Obligations under finance leases
20
68,100
47,680
Trade creditors
947,609
1,370,322
Amounts owed to group undertakings
500
500
Corporation tax
172,862
218,933
Other taxation and social security
225,169
192,064
Other creditors
11,487
7,784
Accruals and deferred income
133,711
98,553
1,559,438
1,935,836
19
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024
2023
Notes
£
£
Obligations under finance leases
20
229,558
191,289
20
FINANCE LEASE OBLIGATIONS
2024
2023
Future minimum lease payments due under finance leases:
£
£
Within one year
82,078
57,814
In two to five years
275,016
230,981
357,094
288,795
Less: future finance charges
(59,436)
(49,826)
297,658
238,969
Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 5 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments. Finance leases are secured against the asset purchased.
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 25 -
21
SECURITY
Shawbrook Bank Limited hold a cross-company guarantee between Hammond Chemicals Limited and Dudley Industrial Holdings Limited dated 14 March 2023.
Freehold land and buildings with a carrying amount of £3,256 (2023 - £18,935 ) have been pledged to secure borrowings of the company. The company is not allowed to pledge these assets as security for other borrowings or to sell them to another entity.
22
DEFERRED TAXATION
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2024
2023
BALANCES:
£
£
Accelerated capital allowances
213,332
179,432
2024
MOVEMENTS IN THE YEAR:
£
Liability at 1 January 2024
179,432
Charge to profit or loss
33,900
Liability at 31 December 2024
213,332
23
RETIREMENT BENEFIT SCHEMES
2024
2023
DEFINED CONTRIBUTION SCHEMES
£
£
Charge to profit or loss in respect of defined contribution schemes
15,063
12,056
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
24
SHARE CAPITAL
2024
2023
2024
2023
ORDINARY SHARE CAPITAL
Number
Number
£
£
ISSUED AND FULLY PAID
Ordinary Shares of £1 each
10,000
10,000
10,000
10,000
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 26 -
25
OPERATING LEASE COMMITMENTS
AS LESSEE
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2024
2023
£
£
Within 1 year
50,000
50,000
Years 2-5
50,000
50,000
100,000
26
RELATED PARTY TRANSACTIONS
TRANSACTIONS WITH RELATED PARTIES
The company has taken advantage of exemption of Section 33 of FRS 102 Related Party Disclosures, not to disclose related party transactions with other group companies.
27
ULTIMATE CONTROLLING PARTY
On 14 March 2023, Dudley Industrial Holdings Limited acquired 100% of the share capital and therefore from this date, became the immediate parent entity. From 14 March 2023, the directors do not consider there to be any ultimate controlling party.
28
CASH GENERATED FROM/(ABSORBED BY) OPERATIONS
2024
2023
£
£
Profit after taxation
2,472,633
3,371,934
ADJUSTMENTS FOR:
Taxation charged
456,891
663,363
Finance costs
20,567
6,971
Investment income
(110,970)
(118,145)
Gain on disposal of tangible fixed assets
(3,571)
(4,349)
Amortisation and impairment of intangible assets
28,945
Depreciation and impairment of tangible fixed assets
176,478
129,485
MOVEMENTS IN WORKING CAPITAL:
Decrease in stocks
114,641
31,871
Decrease/(increase) in debtors
426,498
(10,124,952)
Decrease in creditors
(350,747)
(629,022)
CASH GENERATED FROM/(ABSORBED BY) OPERATIONS
3,231,365
(6,672,844)
HAMMOND CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 27 -
29
ANALYSIS OF CHANGES IN NET FUNDS
1 January 2024
Cash flows
New leases
31 December 2024
£
£
£
£
Cash at bank and in hand
1,234,076
(431,829)
-
802,247
Lease liabilities
(238,969)
43,411
(102,100)
(297,658)
995,107
(388,418)
(102,100)
504,589
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200Mr M J DominikMr T R E NormantonMr M G SilverMr J E Ward009648292024-01-012024-12-3100964829bus:Director12024-01-012024-12-3100964829bus:Director22024-01-012024-12-3100964829bus:Director32024-01-012024-12-3100964829bus:Director42024-01-012024-12-3100964829bus:RegisteredOffice2024-01-012024-12-31009648292024-12-31009648292023-01-012023-12-3100964829core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3100964829core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3100964829core:IntangibleAssetsOtherThanGoodwill2024-12-3100964829core:IntangibleAssetsOtherThanGoodwill2023-12-3100964829core:ComputerSoftware2024-12-3100964829core:ComputerSoftware2023-12-31009648292023-12-3100964829core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3100964829core:PlantMachinery2024-12-3100964829core:ComputerEquipment2024-12-3100964829core:MotorVehicles2024-12-3100964829core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3100964829core:PlantMachinery2023-12-3100964829core:ComputerEquipment2023-12-3100964829core:MotorVehicles2023-12-3100964829core:ShareCapital2024-12-3100964829core:ShareCapital2023-12-3100964829core:RetainedEarningsAccumulatedLosses2024-12-3100964829core:RetainedEarningsAccumulatedLosses2023-12-3100964829core:ShareCapital2022-12-3100964829core:RetainedEarningsAccumulatedLosses2022-12-3100964829core:ShareCapitalOrdinaryShareClass12024-12-3100964829core:ShareCapitalOrdinaryShareClass12023-12-31009648292023-12-31009648292022-12-3100964829core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3100964829core:ComputerSoftware2024-01-012024-12-3100964829core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3100964829core:PlantMachinery2024-01-012024-12-3100964829core:ComputerEquipment2024-01-012024-12-3100964829core:MotorVehicles2024-01-012024-12-310096482912024-01-012024-12-310096482912023-01-012023-12-3100964829core:UKTax2024-01-012024-12-3100964829core:UKTax2023-01-012023-12-3100964829core:ComputerSoftware2023-12-3100964829core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssets2024-01-012024-12-3100964829core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3100964829core:PlantMachinery2023-12-3100964829core:ComputerEquipment2023-12-3100964829core:MotorVehicles2023-12-3100964829core:Non-currentFinancialInstruments2024-12-3100964829core:Non-currentFinancialInstruments2023-12-3100964829core:Non-currentFinancialInstrumentscore:ListedExchangeTraded2024-12-3100964829core:Non-currentFinancialInstrumentscore:ListedExchangeTraded2023-12-3100964829core:Subsidiary12024-01-012024-12-3100964829core:Subsidiary22024-01-012024-12-3100964829core:Subsidiary32024-01-012024-12-3100964829core:Subsidiary42024-01-012024-12-3100964829core:Subsidiary52024-01-012024-12-3100964829core:Subsidiary112024-01-012024-12-3100964829core:Subsidiary222024-01-012024-12-3100964829core:Subsidiary332024-01-012024-12-3100964829core:Subsidiary442024-01-012024-12-3100964829core:Subsidiary552024-01-012024-12-3100964829core:CurrentFinancialInstruments2024-12-3100964829core:CurrentFinancialInstruments2023-12-3100964829core:WithinOneYear2024-12-3100964829core:WithinOneYear2023-12-3100964829core:BetweenTwoFiveYears2024-12-3100964829core:BetweenTwoFiveYears2023-12-3100964829bus:OrdinaryShareClass12024-01-012024-12-3100964829bus:OrdinaryShareClass12024-12-3100964829bus:OrdinaryShareClass12023-12-3100964829bus:PrivateLimitedCompanyLtd2024-01-012024-12-3100964829bus:FRS1022024-01-012024-12-3100964829bus:Audited2024-01-012024-12-3100964829bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP